Breast carcinomas occurring in young women (< 35 years) are different. - Wikidata - wikimedia - TriplyDB

Breast carcinomas occurring in young women (< 35 years) are different.

Breast carcinomas occurring in young women (< 35 years) are different.

http://www.wikidata.org/entity/Q36141250

about

Young age: an independent risk factor for disease-free survival in women with operable breast cancer Managing breast cancer in younger women: challenges and solutions Unique features of young age breast cancer and its management Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers Identification of inherited genetic variations influencing prognosis in early-onset breast cancer Correlation of Tumoral Prognostic Factors by Sonoelastography Score in Patients to be Operated Due to Breast Cancer.Breast cancer in young women: poor survival despite intensive treatment.Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience Parallel routes of human carcinoma development: implications of the age-specific incidence data Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.Breast cancer in moroccan young women: a retrospective study.Immunohistochemical prognostic index for breast cancer in young women.Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.Post-mastectomy radiotherapy can improve survival in breast cancer patients aged 35 years or younger with four or more positive nodes but not in one to three positive nodes.Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience.Risk factors and natural history of breast cancer in younger Chinese women.Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.Comparison of Clinical Features and Treatment Outcome of Breast Cancers in Young and Elderly Chinese Patients Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer.The role of ovarian ablation in the management of breast cancer.Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients.Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG)Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study The aged breast.Treatment of breast cancer in young women: do we need more aggressive therapies?Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.Addressing fertility needs of breast cancer patients: oncology perspective.Factors influencing the effect of age on prognosis in breast cancer: population based study.Physiological COX-2 expression in breast epithelium associates with COX-2 levels in ductal carcinoma in situ and invasive breast cancer in young women Postmastectomy radiation and recurrence patterns in breast cancer patients younger than age 35 years: a population-based cohort.Do younger female breast cancer patients have a poorer prognosis? Results from a population-based survival analysis.Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008.Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study.C-erbB-2 overexpression and survival in early onset breast cancer.Very young women (<35 years) with operable breast cancer: features of disease at presentation.

P2860

Q24791855-18BAC6C3-BF8C-4F9B-A1F1-B9F7DFF35702 Q26771184-0FB713D7-993C-4EAC-95C1-9275F0F3EF40 Q26821902-E4D614CF-CE13-476F-9895-DF1D4828BE54 Q28265762-275570F1-4390-4C8A-90DF-9DCF13898CBD Q28943279-A56CDA44-7E2D-48DA-913F-3B493D733157 Q30368677-E26D6F36-42D0-428F-81A2-8E0201DFD24A Q30882889-48ABB55F-E8F5-45C6-8265-E26B2E310713 Q33308326-E562FD79-0BF6-45CD-91F1-A4EA70864997 Q33506089-93E0BBFF-798A-4290-A31F-F92022F9E6EC Q33592683-0A801C7C-33E0-4547-B320-12EB69546CE7 Q33699658-DF9D3850-29D4-4EDA-817C-88BAD0588663 Q33741050-C6AEAE71-3013-4606-8254-990EB41C02D5 Q33919270-5D51819D-93E4-4A10-AD90-4E1EE8E157F2 Q34173505-DC9B20F4-9E14-42FA-8A01-467FBB3A3546 Q34351227-21D2A917-9064-437C-84BE-4FF8C737EB5F Q34464227-9FA094B2-2906-47AA-A0D0-D3D80B82BC47 Q34657634-BF0858D8-8D9F-43DB-BF86-C02DCAE9D243 Q35592936-206E9BEF-26B7-4206-9EBA-27853CB252B7 Q35789382-874D16C3-A834-4240-9CB7-2EF6D7998033 Q36089922-4D845547-1EF0-44BD-85F3-D5AAF0842CEA Q36317136-6BE43632-DCFE-43F8-B787-CA6B5C5A67AD Q36414528-8C88BDFC-6FD1-4A1C-8162-2F7AFD51ED51 Q36609883-18231CB0-E1CF-4EDF-85E4-C9833F90C665 Q36615701-027CA4E0-09D0-4C08-9F0C-FA8F8DC8A47E Q36617670-7363397F-ED53-4AE3-9392-71E3E28B6BD2 Q36619429-C430C379-1B56-4B39-87F2-649C26931F64 Q36622851-82BC5656-A503-4EA8-AE58-373BB6FF9572 Q36698225-45A4E167-B1BD-4C84-80EB-4C260E10BC24 Q36963389-A5C7587B-B62C-4102-93CA-A18F10183466 Q37006537-3ABDE911-957C-43DD-9BD7-5269371E13CA Q37054462-65D6C029-725A-4155-8A4E-63AC7B7274C1 Q37242682-1306F689-8517-4862-85A1-A7F8E79E394F Q37310432-B823DB2A-05E2-439A-9FF1-EB315B5ADE25 Q37672896-E49D6154-D270-4770-9461-C7C53D873EDE Q38154496-9B7468AF-8037-45B6-91E3-37F43B938E9B Q38480922-10257290-7697-4A52-B273-6B4A2A5EC21B Q39436785-C3770510-855A-43A3-8EC4-A3AD0E269B71 Q43524806-7B7895BA-21AD-4E16-A880-CD9C1A1C85F4 Q43882782-D81F7443-66D1-4228-9AF8-872123C405D4 Q43910363-267BCAF8-6D2D-465B-81BA-94D34CE09F74

P2860

Breast carcinomas occurring in young women (< 35 years) are different.

http://www.wikidata.org/entity/Q36141250

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Breast carcinomas occurring in young women (< 35 years) are different.

@ast

Breast carcinomas occurring in young women (< 35 years) are different.

@en

type

label

Breast carcinomas occurring in young women (< 35 years) are different.

@ast

Breast carcinomas occurring in young women (< 35 years) are different.

@en

prefLabel

Breast carcinomas occurring in young women (< 35 years) are different.

@ast

Breast carcinomas occurring in young women (< 35 years) are different.

@en

P1433

Q36141250-7DD893E2-C501-4987-ACED-5D954742E6DD

P1476

Q36141250-9F931156-511E-47AE-BB6F-39FD74671CA9

P2093

Q36141250-37F89D46-ACBA-4ED4-A3C9-0C1E46EFE46A

Q36141250-83DEB153-9707-4A52-A399-FE151F9682CF

Q36141250-C1D34BA2-1B67-4F3E-A680-4B5320FE3C4B

Q36141250-C4ECD2F7-5613-44BE-8428-7BC1B032E8B6

P2860

Q36141250-151CAA40-A8AE-4A94-82DF-B4A3222200DF

Q36141250-1AB5A7DA-2948-4052-B9CA-1F49DE9916C1

Q36141250-3375A285-3729-43BD-9704-5FEECFD555C7

Q36141250-33F31DE2-4DCB-457D-BBC2-D62C147C5A75

Q36141250-38EF4374-3242-4387-BF3D-03287E9511FD

Q36141250-3D209853-A0BA-4A7E-BB31-BB6C529A0360

Q36141250-51BF7A5F-8C26-454B-AB62-22004820EB9C

Q36141250-52839ECA-129F-4276-AF34-378758F882F1

Q36141250-64F9ED81-4E0E-4251-8172-91044EA75DD9

Q36141250-855ECF38-ADAE-4AFE-B4C2-D4115AD8650A

P2888

Q36141250-36DD518D-8D18-4A28-81B7-29F85B97EF90

P304

Q36141250-867CD3DB-2DFB-4D4F-98AB-16DEFBDFC5CA

P31

Q36141250-909FD44E-AF25-4E37-B194-5D24143A7D10

P356

Q36141250-5083290F-ADDC-4AAF-BB5D-ACD2D2DE9C76

P407

Q36141250-B8E21696-9B7A-4BFA-8263-5B089FF008A3

P433

Q36141250-3C6AE5AB-D0D0-42EE-B80D-29E4A9D8E8A5

P478

Q36141250-D91CC3AA-0227-450A-AC30-902A4466C3E9

P577

Q36141250-D5839D35-3010-4DF4-B716-DA5149234B08

P5875

Q36141250-DA9927B3-2D83-41F8-9F9A-A26B0CBE4A30

P698

Q36141250-8B519ECD-95A7-4D9B-9BE3-38155B6D06DB

P932

Q36141250-794FB37B-05EE-4A9E-8DC8-FAC5AD9669FA

P356

P1433

British Journal of Cancer

P1476

Breast carcinomas occurring in young women (< 35 years) are different.

@en

P2093

Dearing SJ

http://www.w3.org/2001/XMLSchema#string

Lees E

http://www.w3.org/2001/XMLSchema#string

Walker RA

http://www.w3.org/2001/XMLSchema#string

Webb MB

http://www.w3.org/2001/XMLSchema#string

P2860

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.

Pathological and biological features of mammographically detected invasive breast carcinomas

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

P2888

P304

1796-1800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1996.632

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

1996-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14250440

http://www.w3.org/2001/XMLSchema#string

P698

8956795

http://www.w3.org/2001/XMLSchema#string

P932

2077218

http://www.w3.org/2001/XMLSchema#string